Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.

Early pregnancy (Online)

Volumn 4, Issue 4, 2000, Pages 230-239

  Papp, C ^a   Schatz, F ^a   Krikun, G ^a   Hausknecht, V ^a   Lockwood, C J ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTIVE AGENT; HORMONE ANTAGONIST; LUTEOLYTIC AGENT; MENSTRUATION INDUCING AGENT; MIFEPRISTONE; ORAL CONTRACEPTIVE AGENT;

CHEMISTRY; DRUG EFFECT; ENDOMETRIUM; FEMALE; HUMAN; METABOLISM; PREGNANCY; REVIEW;

ABORTIFACIENT AGENTS, STEROIDAL; CONTRACEPTIVES, ORAL, SYNTHETIC; ENDOMETRIUM; FEMALE; HORMONE ANTAGONISTS; HUMANS; LUTEOLYTIC AGENTS; MENSTRUATION-INDUCING AGENTS; MIFEPRISTONE; PREGNANCY;

EID: 0034305903     PISSN: None     EISSN: 15376583     Source Type: Journal    
DOI: None     Document Type: Review

References (40)